FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

Retrieved on: 2025-04-03 22:39:54

Tags for this article:

COVID-19 vaccination in the United States

RNA vaccines

Novavax

COVID-19 pandemic by country

Pfizer-BioNTech COVID-19 vaccine

COVID-19 vaccine

Emergency use authorization

Sanofi

Click the tags to see associated articles and topics

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS. View article details on hiswai:

Excerpt

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has passed with no clarity ...

Article found on: finance.yahoo.com

View Original Article